Additionally, the use of EVs to deliver small interfering RNAs (siRNAs) targeting HIF-1α and STAT3 to BC tissues might increase CTL and IFN-γ levels, thereby enhancing local antitumor immunity in the BC TME [269]. Here, HIF1A is linked to breast cancer.